Medical Journals

Effects of Type I Interferons on the Adjuvant Properties of Plasmid Granulocyte-macrophage Colony-stimulating Factor in Vivo.

Authors:
  • Qin Lizeng
  • Greenland John R
  • Moriya Chikaya
  • Cayabyab Mark J
  • Letvin Norman L

From: Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave., Boston, MA 02215, USA.

Journal of virology

  • Publish Date: Oct 2007
  • ISSN: 0022-538X
  • Volume: 81
  • Issue: 19
  • Pages: 10606-13
  • Medium: Print
  • Language: English
  • Citation (JAMA): Qin Lizeng, Greenland John R, Moriya Chikaya, et al. Effects of Type I Interferons on the Adjuvant Properties of Plasmid Granulocyte-macrophage Colony-stimulating Factor in Vivo.. J. Virol. Oct 2007;81:10606-13

Abstract

While administration of granulocyte-macrophage colony-stimulating factor (GM-CSF) can induce the local recruitment of activated antigen-presenting cells at the site of vaccine inoculation, this cellular recruitment is associated with a paradoxical decrease in local vaccine antigen expression and vaccine-elicited CD8+ T-cell responses. To clarify why this cytokine administration does not potentiate immunization, we examined the recruited cells and expressed inflammatory mediators in muscles following intramuscular administration of plasmid GM-CSF in mice. While large numbers of dendritic cells and macrophages were attracted to the site of plasmid GM-CSF inoculation, high concentrations of type I interferons were also detected in the muscles. As type I interferons have been reported to damp foreign gene expression in vivo, we examined the possibility that these local innate mediators might decrease plasmid DNA expression and therefore the immunogenicity of plasmid DNA vaccines. In fact, we found that coadministration of an anti-beta interferon monoclonal antibody with the plasmid DNA immunogen and plasmid GM-CSF restored both the local antigen expression and the CD8+ T-cell immunogenicity of the vaccine. These data demonstrate that local innate immune responses can change the ability of vaccines to generate robust adaptive immunity.

Mesh Headings (Keywords): Animals, Antibodies, Monoclonal, Antigen Presentation, Antigen-Presenting Cells, Dendritic Cells, Female, Granulocyte-Macrophage Colony-Stimulating Factor, Immunity, Natural, Interferon Type I, Interferon-beta, Mice, Mice, Inbred BALB C, Muscle, Skeletal, Plasmids, Th1 Cells, Vaccines, DNA


Check for Full Text / PubMed Unique Identifier (PMID): 17652387


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.